Form 4: IQVIA Director Jim Fasano Boosts Equity Stake with Deferred Share Acquisition

IQVIA Holdings Inc. Director Jim Fasano acquired 187 deferred shares, increasing his beneficial ownership to 3,870 deferred shares.

Summary

• Jim Fasano, a Director at IQVIA Holdings Inc. (IQV), acquired 187 deferred shares.
• The transaction occurred on July 24, 2025.
• Each deferred share is convertible into one share of IQVIA common stock upon settlement.
• Settlement conditions for the deferred shares include cessation as a director, a change in company control, or the reporting person's death, with no expiry date.
• Following this transaction, Mr. Fasano beneficially owns a total of 3,870 derivative securities, specifically deferred shares.
• The underlying common stock value associated with the deferred shares was $200.82 per share.

Sentiment

Score: 7

Explanation: The acquisition of additional deferred shares by a director is generally a positive signal, indicating continued alignment of interests with the company's long-term performance, though it's a routine compensation event rather than a discretionary purchase.

Positives

• Director Jim Fasano increased his beneficial ownership in IQVIA Holdings Inc. by acquiring additional deferred shares.
• The acquisition of deferred shares aligns the director's long-term interests with shareholder value creation.

Future Outlook

The deferred shares are designed to settle into common stock upon specific future events, such as the reporting person ceasing to be a director, a change in company control, or the reporting person's death, indicating a long-term incentive structure.

Industry Context

This transaction is a routine insider filing, common in the healthcare information and clinical research industry, where executive and director compensation often includes equity-based incentives like deferred shares to align long-term interests with company performance.

Comparison to Industry Standards

• The use of deferred shares as part of director compensation is a standard practice across various industries, including healthcare and technology, aligning director incentives with long-term company performance.
• Similar to other large-cap companies in the pharmaceutical services and technology sector, IQVIA utilizes equity compensation to retain and incentivize its leadership.

Stakeholder Impact

• Shareholders: The increase in director ownership through deferred shares aligns the director's interests with shareholder value creation over the long term.

Key Dates

Recommendation

This Form 4 filing reports a routine acquisition of deferred shares by a director as part of their compensation. While it indicates continued alignment of interests, it is not a discretionary open-market purchase and does not provide new material information to warrant a change in investment recommendation. It's a standard disclosure for insider equity holdings.

Keywords

IQVIA Holdings Inc., IQV, Jim Fasano, Director, Deferred Shares, Insider Transaction, SEC Form 4, Beneficial Ownership, Equity Compensation